Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (101-110 of 953) with videos related to

Pageof 96
Sort By:
Neurobiology of Aging|June 26, 2020
Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's diseaseEllen Dicks, Wiesje M van der Flier, Philip Scheltens, et al.
Neuroimage|June 18, 2005
Delayed rather than decreased BOLD response as a marker for early Alzheimer's diseaseSerge A R B Rombouts, Rutger Goekoop, Cornelis J Stam, et al.
Dementia and Geriatric Cognitive Disorders|July 6, 2016
White Matter Changes and Cognitive Decline in a Ten-Year Follow-Up Period: A Pilot Study on a Single-Center Cohort from the Leukoaraiosis and Disability StudySofia Madureira, Ana Verdelho, Carla Moleiro, et al.
BMC Health Services Research|April 3, 2026
Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling studyPattara Leelahavarong, Juthamas Prawjaeng, Pakkanan Angkab, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2010
[Vascular cognitive impairment]Hanna Martha Boss, Renske M van den Berg-Vos, Philip Scheltens, et al.
Journal of the American Geriatrics Society|December 29, 2018
Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100-Plus StudyNina Beker, Sietske A M Sikkes, Marc Hulsman, et al.
Human Brain Mapping|June 15, 2005
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI studySerge A R B Rombouts, Frederik Barkhof, Rutger Goekoop, et al.
Nature Reviews. Neurology|February 9, 2010
The clinical use of structural MRI in Alzheimer diseaseGiovanni B Frisoni, Nick C Fox, Clifford R Jack, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?Marta Del Campo Milan, Leah Zuroff, Connie R Jimenez, et al.
Journal of Clinical and Translational Research|March 16, 2019
Patients to learn from: on the need for systematic integration of research and care in academic health careMartin Boeckhout, Philip Scheltens, Peggy Manders, et al.
Pageof 96

Showing results (101-110 of 953) with videos related to

Sort By:
Pageof 96
Neurobiology of Aging|June 26, 2020
Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's diseaseEllen Dicks, Wiesje M van der Flier, Philip Scheltens, et al.
Neuroimage|June 18, 2005
Delayed rather than decreased BOLD response as a marker for early Alzheimer's diseaseSerge A R B Rombouts, Rutger Goekoop, Cornelis J Stam, et al.
Dementia and Geriatric Cognitive Disorders|July 6, 2016
White Matter Changes and Cognitive Decline in a Ten-Year Follow-Up Period: A Pilot Study on a Single-Center Cohort from the Leukoaraiosis and Disability StudySofia Madureira, Ana Verdelho, Carla Moleiro, et al.
BMC Health Services Research|April 3, 2026
Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling studyPattara Leelahavarong, Juthamas Prawjaeng, Pakkanan Angkab, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2010
[Vascular cognitive impairment]Hanna Martha Boss, Renske M van den Berg-Vos, Philip Scheltens, et al.
Journal of the American Geriatrics Society|December 29, 2018
Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100-Plus StudyNina Beker, Sietske A M Sikkes, Marc Hulsman, et al.
Human Brain Mapping|June 15, 2005
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI studySerge A R B Rombouts, Frederik Barkhof, Rutger Goekoop, et al.
Nature Reviews. Neurology|February 9, 2010
The clinical use of structural MRI in Alzheimer diseaseGiovanni B Frisoni, Nick C Fox, Clifford R Jack, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?Marta Del Campo Milan, Leah Zuroff, Connie R Jimenez, et al.
Journal of Clinical and Translational Research|March 16, 2019
Patients to learn from: on the need for systematic integration of research and care in academic health careMartin Boeckhout, Philip Scheltens, Peggy Manders, et al.
Pageof 96